Market revenue in 2022 | USD 150.2 million |
Market revenue in 2030 | USD 281.0 million |
Growth rate | 8.1% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.31% in 2022. Horizon Databook has segmented the Brazil molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Growing pharmaceutical and biotechnology sectors in Brazil have a major impact on the increasing use of molecular biology enzymes, kits, and reagents in the country. The growth of Brazilian biotechnology industry is backed up by increasing investments for the development of innovative solutions.
In addition, various biotechnology research projects are ongoing in the country, which are focused on human health. This is expected to propel the market growth for molecular biology.
Furthermore, increasing demand for detection of various diseases and molecular diagnostics is anticipated to result in increasing use of molecular biology enzymes, kits, and reagents.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Brazil molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account